Oct. 25, 2005 — The European Medicine Evaluation Agency has approved orphan drug status for the phytomedicine niprisan in the treatment of sickle cell disease; Germany's Federal Institute for Drugs ...
Generic drug company Mylan Inc. and Teva have settled their dispute over Mylan’s plans to sell a generic version of the sleep disorder drug Provigil. Teva (NYSE:TEVA) is primarily a generic drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results